Healthcare provider profile · identity verified

John Payne, MD

Internal Medicine · JACKSON, MS · NPI 1760451991

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	724	248
Atorvastatin Calcium	Atorvastatin Calcium	538	182
Gabapentin	Gabapentin	429	144
Pantoprazole Sodium	Pantoprazole Sodium	412	134
Potassium Chloride	Potassium Chloride	371	117
Losartan Potassium	Losartan Potassium	308	95
Furosemide	Furosemide	307	112
Metformin Hcl	Metformin Hcl	305	93
Hydrochlorothiazide	Hydrochlorothiazide	302	96
Levothyroxine Sodium	Levothyroxine Sodium	255	69
Meloxicam	Meloxicam	242	88
Fluticasone Propionate	Fluticasone Propionate	220	95
Metoprolol Succinate	Metoprolol Succinate	210	62
Omeprazole	Omeprazole	207	64
Carvedilol	Carvedilol	190	55
Lisinopril	Lisinopril	190	71
Albuterol Sulfate Hfa	Albuterol Sulfate	174	65
Hydralazine Hcl	Hydralazine Hcl	163	50
Naproxen	Naproxen	155	51
Tamsulosin Hcl	Tamsulosin Hcl	155	48
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	151	63
Clonidine Hcl	Clonidine Hcl	150	47
Ozempic	Semaglutide	147	29
Allopurinol	Allopurinol	122	38
Azithromycin	Azithromycin	117	79
Diclofenac Sodium	Diclofenac Sodium	114	62
Jardiance	Empagliflozin	114	31
Paroxetine Hcl	Paroxetine Hcl	112	38
Eliquis	Apixaban	110	32
Rosuvastatin Calcium	Rosuvastatin Calcium	105	37
Sertraline Hcl	Sertraline Hcl	103	28
Metoprolol Tartrate	Metoprolol Tartrate	102	34
Amitriptyline Hcl	Amitriptyline Hcl	97	33
Clopidogrel	Clopidogrel Bisulfate	96	32
Lovastatin	Lovastatin	92	29
Zolpidem Tartrate	Zolpidem Tartrate	90	22
Donepezil Hcl	Donepezil Hcl	86	28
Isosorbide Mononitrate Er	Isosorbide Mononitrate	80	24
Glipizide	Glipizide	78	23
Pregabalin	Pregabalin	78	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	25
Pravastatin Sodium	Pravastatin Sodium	75	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	74	57
Tizanidine Hcl	Tizanidine Hcl	70	23
Hydroxyzine Hcl	Hydroxyzine Hcl	69	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	68	22
Meclizine Hcl	Meclizine Hcl	67	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	19
Linzess	Linaclotide	65	24
Colchicine	Colchicine	64	25
Topiramate	Topiramate	64	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	62	27
Duloxetine Hcl	Duloxetine Hcl	61	24
Ondansetron Hcl	Ondansetron Hcl	59	29
Prednisone	Prednisone	59	29
Glipizide Er	Glipizide	58	19
Ibuprofen	Ibuprofen	58	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	19
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	54	suppressed
Levetiracetam	Levetiracetam	52	19
Cyproheptadine Hcl	Cyproheptadine Hcl	51	16
Spironolactone	Spironolactone	51	17
Alprazolam	Alprazolam	50	19
Atenolol	Atenolol	49	16
Buspirone Hcl	Buspirone Hcl	49	suppressed
Hydrocortisone	Hydrocortisone	48	28
Montelukast Sodium	Montelukast Sodium	48	19
Olmesartan Medoxomil	Olmesartan Medoxomil	45	13
Ezetimibe	Ezetimibe	42	17
Indomethacin	Indomethacin	42	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	33
Simvastatin	Simvastatin	42	16
Chlorthalidone	Chlorthalidone	41	14
Escitalopram Oxalate	Escitalopram Oxalate	40	12
Trazodone Hcl	Trazodone Hcl	40	16
Promethazine Hcl	Promethazine Hcl	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	37	15
Nifedipine Er	Nifedipine	36	11
Mirtazapine	Mirtazapine	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	15
Valacyclovir	Valacyclovir Hcl	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Famotidine	Famotidine	31	12
Finasteride	Finasteride	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	16
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Mupirocin	Mupirocin	25	19
Januvia	Sitagliptin Phosphate	24	suppressed
Fluconazole	Fluconazole	23	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	20
Estradiol	Estradiol	21	suppressed
Lactulose	Lactulose	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Ventolin Hfa	Albuterol Sulfate	19	11
Cilostazol	Cilostazol	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Amoxicillin	Amoxicillin	15	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Nitroglycerin	Nitroglycerin	15	11
Ranolazine Er	Ranolazine	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Tramadol Hcl	Tramadol Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Cephalexin	Cephalexin	12	11
Clonazepam	Clonazepam	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Glyburide	Glyburide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Metolazone	Metolazone	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Valsartan	Valsartan	12	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error